Brainstorm Cell Therapeutics | BCLI - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Biogen USD 554.3M 128.2M 2026-03
Brainstorm Cell Therapeutics USD 1.39M 326K 2025-12
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.21M 120K 2025-12
CSL USD 1.23B 498M 2025-12
Cytokinetics USD 91.72M 67.02M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
Grifols EUR 320.45M 12.65M 2025-12
Halozyme Therapeutics USD 64.64M 27.11M 2025-12
Mesoblast USD 28.54M 9.69M 2025-12